ENDONOVO THERAPEUTICS, INC. (ENDV) Total liabilities 2013–2022
ENDONOVO THERAPEUTICS, INC. (ENDV) total liabilities at each fiscal year-end, per SEC filings.
$33.5MFY2022 · since FY2013: $4.2M → $33.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $33.5M | +88.2% |
| FY2021 | $17.8M | +4.7% |
| FY2020 | $17.0M | -28.6% |
| FY2019 | $23.8M | +52.1% |
| FY2018 | $15.6M | — |
| FY2015 | $9.7M | +104.4% |
| FY2014 | $4.7M | +12.7% |
| FY2013 | $4.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ENDV financial trends
ENDV RevenueENDV Net incomeENDV Net marginENDV Gross profitENDV Gross marginENDV Operating incomeENDV Operating marginENDV Operating cash flowENDV Free cash flowENDV Capital expendituresENDV Return on equityENDV Stock buybacksENDV Dividends paidENDV Total assetsENDV Shareholders’ equityENDV overview →